| The outcome of COVID-19 in patients with hematological malignancy P Tığlıoğlu, M Albayrak, M Tığlıoğlu, HBA Öztürk, MR Aras, B Sağlam, ... memo-Magazine of European Medical Oncology, 1-7, 2021 | 8 | 2021 |
| Hypercalcemia associated with the interaction between all trans retinoic acid and posaconazole in an acute promyelocytic leukemia case HB Afacan Ozturk, M Albayrak, S Maral, M Reis Aras, F Yilmaz, P Akyol, ... Journal of Oncology Pharmacy Practice 27 (8), 2027-2029, 2021 | 7 | 2021 |
| Hereditary breast-ovarian cancer and BRCA1/BRCA2 variants: a single center experience A Gezdirici, EG İli, B Değirmenci, AA Gümüş, G Özdemir, NA Erman, ... Acta Oncologica Turcica 54 (3), 264-272, 2021 | 6 | 2021 |
| Thrombocytopenia due to rivaroxaban: A rare adverse effect M Tığlıoğlu, P Akyol, B Sağlam, MR Aras, HBA Öztürk, A Yıldız, ... Transfusion and Apheresis Science 59 (6), 102883, 2020 | 5 | 2020 |
| Effect of blood groups on clinical presentations and treatment outcomes in immune thrombotic thrombocytopenic purpura patients with severe ADAMTS13 deficiency: a multi-center … M Yıldırım, S Sayın, AK Güneş, M Reis Aras, E Safak Yılmaz, M Albayrak, ... Transfusion Medicine and Hemotherapy 50 (1), 18-25, 2023 | 4 | 2023 |
| Ibrutinib-induced polyneuropathy: A case report P Cömert, M Albayrak, A Yıldız, O Şahin, HB Öztürk, M Reis Aras Journal of Oncology Pharmacy Practice 26 (6), 1501-1504, 2020 | 4 | 2020 |
| Mean platelet volume is a predictive and prognostic marker for patients with acute myeloid leukemia: a two-center retrospective analysis M Tığlıoğlu, M Albayrak, S Doğan, F Yılmaz, P Akyol, B Sağlam, ... Leukemia & Lymphoma 62 (11), 2755-2761, 2021 | 3 | 2021 |
| A signet ring cell carcinoma presented as refractory acquired thrombotic thrombocytopenic purpura UY Malkan, M Albayrak, HB Ozturk, M Reis Aras, B Saglam, K Dogan Case Reports in Oncology 13 (3), 1368-1372, 2021 | 3 | 2021 |
| Comparison of maintenance regimens in Acute Promyelocytic Leukemia patients EK Gunes, ZN Ozkurt, S Yildiz, G Ozet, F Ceran, M Albayrak, MR Aras, ... Leukemia Research 128, 107055, 2023 | 2 | 2023 |
| Leukocytoclastic vasculitis due to ruxolitinib treatment: A rare adverse effect M Tığlıoğlu, P Tığlıoğlu, A Yıldız, M Reis Aras, B Sağlam, ... Journal of Clinical Pharmacy and Therapeutics 47 (4), 544-547, 2022 | 2 | 2022 |
| Relationship between Dynamic MRI findings and the prognostic factors of breast cancer H Aydın, B Güner, I Esen Bostancı, A Coşkun Bilge, ZM Bulut, B Arıbaş, ... Acta Oncologica Turcica 54 (2), 128-140, 2021 | 2 | 2021 |
| CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study U Demirci, HO Kırkızlar, EG Ümit, V Gürsoy, İE Pınar, F Özkalemkaş, ... Journal of Hematopathology 15 (4), 203-213, 2022 | 1 | 2022 |
| Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment F Yılmaz, M Albayrak, P Tığlıoğlu, M Tığlıoğlu, B Sağlam, M Reis Aras, ... Journal of Oncology Pharmacy Practice 28 (3), 725-728, 2022 | 1 | 2022 |
| Analysis of demographic and clinical characteristics of primary myelofibrosis and post-polycythemia vera/essential thrombocythemia myelofibrosis patients P Akyol, A Yıldız, M Albayrak, HBA Öztürk, S Maral, MR Aras, F Yılmaz, ... Gülhane Tip Dergisi 63 (2), 117, 2021 | 1 | 2021 |
| The Importance of Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic Leukemia HBA Ozturk, M Albayrak, A Yildiz, S Maral, P Akyol, MR Aras, M Falay International Journal of Hematology and Oncology 33 (1), 199-204, 2021 | 1 | 2021 |
| Mean platelet volume and platelet distribution width in the prediction of treatment response in immune thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a … S Sayın, M Yıldırım, AK Güneş, MR Aras, EŞ Yılmaz, M Albayrak, G Özet, ... Gulhane Medical Journal, 2024 | | 2024 |
| The Utility of CONUT Score in Indolent Lymphoma Patients M Tighoglu, HBA Ozturk, A Yildiz, P Tighoglu, F Yilmaz, MR Aras, ... Nigerian Journal of Clinical Practice 26 (9), 1290-1296, 2023 | | 2023 |
| The prognostic impact of comorbidity, nutritional and performance status on patients with diffuse large B cell lymphoma B Sağlam, M Albayrak, A Yıldız, P Tığlıoğlu, M Tığlıoğlu, MR Aras, ... Nigerian Journal of Clinical Practice 26 (10), 1512-1518, 2023 | | 2023 |
| In the management of febrile neutropenia; evaluation of the factors affecting the lenght of hospital stay F Yılmaz, B Sağlam, MR Aras, HBA Öztürk, HH Çayköylü, AMY Gülçiçek, ... Turkish Journal of Clinics and Laboratory 14 (3), 587-591, 2023 | | 2023 |
| The Charlson Comorbidity Index Predicts Poor Prognosis in Elderly AML Patients M Tığlıoğlu, M Albayrak, P Tığlıoğlu, A Yıldız, S Doğan, HB Afacan Öztürk, ... UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2023 | | 2023 |
Murat AlbayrakSB Ankara Etlik Şehir Hastanesi. Hematoloji KliniğiVerified email at saglik.gov.tr
